Press Releases

Viscira® Races for Multiple Myeloma

Viscira Participates in Fundraising Event for Multiple Myeloma Research Foundation

San Francisco, CA - April 23, 2013 Viscira, a leading provider of interactive, new-media communication and technology solutions for the life sciences industry, joined several of its life sciences clients on Sunday, April 7th, for a 5K walk/run event in San Francisco to help raise funds and awareness of multiple myeloma.

“It was a very worthwhile event that we were proud to participate in as a company”, said Dave Gulezian, President & CEO of Viscira. “We have developed product solutions for clients like Onyx and Celgene in the area of multiple myeloma and are familiar with this type of cancer. However, this event helped to personalize the impact that this disease can have for many of us.”

The company plans to make this an annual event and further increase its presence. “Not only is it a great opportunity for Viscira employees to give back, but it is also a chance for employees to bond outside of the workplace,” explained Noël Ashekian, Marketing Communications Manager for Viscira.

About Viscira

Viscira is dedicated to the design and development of new-media communication solutions and interactive software applications for the life sciences industry. Viscira provides a suite of programs that provide best-in-class technology solutions to deliver engaging and memorable content via various electronic channels. For more information, please visit the company’s website at or contact Noёl Ashekian at (617) 429-0834.

About the MMRF Race For Research

Held annually in nine cities across the country -- Atlanta, Boston, Chicago, Philadelphia, San Francisco, St. Louis, Tri-State (New Canaan, CT), Twin Cities, and Washington D.C. -- this family friendly 5K walk/run raises both awareness and funds for multiple myeloma. Since its inception in 2001 in Chicago, the MMRF Race for Research program has raised more than $17 million to support the Multiple Myeloma Research Foundation’s urgent work.

About the MMRF

The MMRF was founded in 1998 as a 501(c)(3) non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy was diagnosed with multiple myeloma, an incurable blood cancer. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure.

Viscira® Releases QuickFlip™ Technology for the Apple iPad® and Other Tablets

Viscira, a leading provider of interactive, new-media communication and technology solutions for the life sciences industry, today announced the release of its QuickFlip technology. This patent-pending software leverages the gyroscope capability of the iPad and other tablet devices to deliver dynamic content that a field sales rep can quickly access based on the physical orientation of the device.

This enables sales reps and other field staff to instantly customize their detailing presentations for longer engagements or for very brief interactions with target healthcare professionals by changing the device from landscape mode to portrait mode and back.

“We developed this technology in response to our clients’ need for more flexibility during their sales calls,” explains Rodwin Pabello, Viscira’s Director of Visual and Interaction Design. “With QuickFlip, field sales staff can really make the most of every interaction with a customer whether it's long or very brief.”

Although QuickFlip is embedded within Viscira’s own vDetail interactive detailing platform, it can also be adapted for other sales detailing and CRM platforms in use in the industry, including Veeva iRep. QuickFlip is currently being deployed for major life science clients.

“We are extremely excited about this new mobile innovation that helps address a key customer need,” says Dave Gulezian, President & CEO of Viscira. “We’re pleased that it’s already generating very positive feedback from clients and look forward to further enhancing this technology.”

QuickFlip is just one example of how Viscira is capitalizing on the growing trend of tablet usage by physicians, patients and life sciences companies. The company continues to see strong demand for its distinctive mobile apps, and will continue to fully leverage its software development expertise and unique production capabilities to make further advancements in this area.

Click here to read the full article

Viscira Generates Strong Revenue Growth in 2012

Viscira, a leading provider of interactive, new-media communication and technology solutions for the life sciences industry, today announced strong operating results for the 2012 fiscal year. Overall, the company realized a nearly 50 percent increase in annual gross revenue over its 2011 financial performance.

This strong growth follows on the heels of a more than 50 percent increase in annual gross revenue in the prior year. Additionally, the company continued to maintain its solid profitability metrics with minimal debt on the balance sheet.

During 2012, Viscira added several major new clients, including GlaxoSmithKline, Biogen Idec, Novo Nordisk, and Quest Diagnostics, to its roster of prominent life sciences customers. The company also continued to expand its volume of business with existing clients such as Genentech-Roche, Johnson & Johnson, Bristol-Myers Squibb, and Novartis.

Viscira’s growth has been driven by increasing demand across the company’s entire portfolio of interactive solutions and software products, including its online speaker portal (OSP) and interactive presentation builder (IPB) platforms, 3D mechanism of action animations, and KOL video presentation modules. Demand for the company’s distinctive sales and educational applications for the iPad also grew significantly over the period.

In addition to increasing company revenue, Viscira released several new products, added key staff in important functional areas such as software development and business development, accelerated R&D activities, expanded to a new office space in NYC, and launched a new corporate website, among many other achievements realized through the year. Additionally, the company added two new patent filings to its growing patent portfolio.

“We are very satisfied with what our team was able to achieve in 2012 through their hard work and dedication,” commented Dave Gulezian, President & CEO of Viscira. “It’s exciting to see that our clients continue to respond in such a positive way to our ongoing product innovation and consistent delivery performance. We look forward to our continued growth and improvement as a company in 2013.

Click here to read the full article

Got Game? Growth in Interactive Gaming Impacts Pharmaceutical Marketing

Whether at home or on the road, playing interactive games has become an increasingly popular way to entertain, pass the time, and engage with friends. With stunning video, 2D and 3D animation, and special effects, these games have also grown increasingly sophisticated and impactful.

According to a new market report issued by Transparency Market Research entitled, “Gaming Market - Global Industry Analysis, Size, Growth, Share and Forecast 2011 - 2015”, the global gaming market was valued at $70.5 billion in 2011. This market is expected to grow over 15% per year and reach a hefty $117.9 billion in 2015.

Overall, the video game industry is one of the fastest growing sectors of the entertainment industry in the United States with the greatest growth likely to come in mobile gaming. A Gartner report called “Market Trends: Gaming Ecosystem, 2011” predicts that mobile gaming will experience the largest growth as compared to other gaming sectors, with its relative market share expected to grow from 15% in 2010 to 20% in 2015.

The desire to have the exciting world of interactive entertainment at your fingertips has helped fuel the growth of major market players like Nintendo, Microsoft and Sony, as well as new mobile gaming companies like Zynga.

Interestingly, the life sciences industry is also taking advantage of this major trend in the increased use and adoption of interactive games. Today, pharma marketers are more aggressively integrating interactive games into their marketing and sales programs. As a result, these programs are becoming much more sophisticated, engaging and interconnected, while increasing in educational value.

Viscira, a leading provider of interactive, new-media and technology solutions for the life sciences industry, is seeing a growing demand for more sophisticated gaming elements in its clients’ digital marketing programs.

Dave Gulezian, President & CEO of Viscira, commented on the increase in demand among its clients for such tools. “Our clients are continually looking for new and innovative ways to communicate their key product marketing and educational messages. When well executed, interactive gaming modules provide ways to both educate and entertain to increase the overall impact of a particular initiative.”

As just one recent example, Viscira successfully integrated real-time 3D gaming software into an interactive iPad-based sales tool for a top-five pharma client. This gaming technology leverages the iPad’s built-in gyroscope, and allows the users to control their viewing perspective in a fully immersive 3D cellular environment -- all just by holding and moving the iPad in space.

“We are constantly looking for new opportunities to integrate unique gaming capabilities into the solutions we offer clients to further enhance their effectiveness,” said Gulezian. “Given the time demands and entertainment expectations of both patients and healthcare professionals, we expect the interest in this area to continue to grow.”

With its creative design skills, 3D animation and video expertise, and software programming capabilities, Viscira is uniquely positioned to deliver sophisticated gaming modules for its clients, including applications for various mobile devices like the iPad, smart phones and other tablet devices.

Click here to read the full article

News by Year Press Releases - News page